Delivery Order SPE2DB25D3020-SPE2DB25FWHUG
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively-procured delivery order by the Defense Logistics Agency on July 10, 2025, for Nucynta ER 100 mg tablets (60 count). The order, valued at $2,944.08 with a firm fixed price structure, is scheduled for completion by July 11, 2025, and will be performed at the company's Conshohocken facility. This award carries no set-aside designation and represents a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 20, 2025, by the Defense Logistics Agency to supply 100 tablets of Nucynta 50 mg, a prescription opioid pain medication. This firm fixed-price delivery order, valued at $2,450.08, is a non-set-aside contract with an ultimate completion date of August 21, 2025, and represents a child order under the company's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Nucynta ER 50 mg tablets in quantities of 60 units. The contract carries a ceiling value of $1,414.00 and features firm fixed pricing with an ultimate completion date of July 25, 2025. This is a non-set-aside award issued competitively and represents a child contract under AmerisourceBergen's existing...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025, for the supply of Nucynta ER Tabs 150mg. This competitive, non-set-aside contract has a ceiling value of $6,849.48 and is structured as a firm fixed price delivery order with an ultimate completion date of August 4, 2025. The award is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Nucynta ER 50 mg tablets (60-count units) with a contract value of $1,990.55. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is set for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Nucynta 50 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,961.06 and is structured as a firm fixed-price delivery order with an ultimate completion date of July 15, 2025. The place of performance is identified as Conshohocken, PA, where...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 1, 2025, by the Defense Logistics Agency (DLA) for the supply of NUCYNTA ER 100 MG tablets (60-count packages) with a ceiling value of $9,298.18. The contract employs firm fixed price terms and is not subject to any set-aside designation, indicating competitive award status. This delivery order is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $12,654.48 by the Defense Logistics Agency Medical Supply Chain for the supply of Nucynta ER 50 mg tablets (60-count units). This firm fixed-price contract, awarded on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a non-competitive set-aside award. The contract will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Nucynta ER is a long-acting opioid pain...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Nucynta ER Tabs 100mg, a prescription opioid pain management medication. This firm fixed-price delivery order, valued at $9,992.08, represents a competitive award with no set-aside designation and is scheduled for completion by July 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,230.11 for Nucynta Tabs 100mg on August 21, 2025. This firm fixed-price contract, which has no set-aside designation, was funded by the Defense Logistics Agency's Medical Supply Chain and will be performed at the awardee's Conshohocken facility, with an ultimate completion date of August 22, 2025. The delivery order represents a short-duration...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWHUGDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,205.75 firm fixed-price delivery order by the Defense Logistics Agency on June 2, 2025, for Nucynta ER 200 mg tablets (60-count supply). The contract, which carries an ultimate completion date of June 3, 2025, represents a non-competitive award and serves the federal medical supply chain supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceuticals and medical commodities worldwide. The award reflects AmerisourceBergen's established role as a critical vendor within the Defense Logistics Agency's pharmaceutical supply network, where the company consistently fulfills delivery orders for brand-name and generic medications across multiple therapeutic domains. As a child contract under the larger IDC, this order for the opioid pain management medication demonstrates the company's ongoing capability to meet federal procurement requirements for specialized pharmaceutical products supporting military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/2/25 |